1,25-(OH)2D3	1,25-Dihydroxyvitamin D3;
1-OHase	1α-Hydroxylase;
ALP	Alkaline phosphatase;
AUC0-t	Area under the plasma concentration-time curve from zero (0) h to time (t);
BMC	Bone mineral content;
BMD	Bone mineral density;
Ca	Calcium;
CaBP	Calcium binding protein;
CaSR	Calcium-sensing receptor;
Cmax	Maximum plasma concentration;
CO2	Carbon dioxide;
CT	Calcitonin;
DPD	Deoxypyridinoline;
EAF	Ethyl acetate-soluble fraction of EE;
ER	Estrogen receptor;
ERE	Estrogen receptor α/β-mediated estrogen response element;
FGF-23	Fibroblast growth factor-23;
FLL	Fructus Ligustri Lucidi;
FLL-EAF	Ethyl acetate-soluble fraction of EE;
FLL-EE	FLL ethanol extract;
FLL-WF	Water-soluble fraction of EE;
K	Drug clearance rate constant from the central chamber to the outside in the one-compartment model.
MRT	The average time of drug molecules retained in vivo after rapid intravenous infusion;
Nox4	NADPH oxidase 4;
NFATc1	Nuclear factor of activated T cell-c1;
NF-κB	Nuclear factor of kappa B;
OA	Oleanolic acid;
OCN	Osteocalcin;
OPG	Osteoprotegerin;
OVX	ovariectomized;
PTH	Parathyroid hormone;
RANK	Receptor activator of nuclear factor kappa B;
RANKL	Receptor activator of nuclear factor kappa B ligand;
ROS	Reactive oxygen species;
T1/2	The time taken a drug to clear from the highest concentration to half of this level;
TCM	Traditional Chinese Medicine;
Tmax	Time at maximum plasma concentration;
TRAP	Tartrate resistant acid phosphatase;
TRPV6	Transient receptor potential vanilloid 6;
UA	Ursolic acid;
VDR	Vitamin D receptor.